Pfenex will use its Pfenex Expression Technology to engineer production strains and processes for Boehringer Ingelheim's proprietary molecules, and molecules from Boehringer Ingelheim's contract manufacturing customers. The companies said the partnership will enable preclinical and clinical development to progress much more quickly and efficiently.
San Diego Union-Tribune
Thursday, 17 February 2011
Pfenex links with Boehringer Ingelheim
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment